407 related articles for article (PubMed ID: 16960500)
1. Cannabinoid receptors in atherosclerosis.
Steffens S; Mach F
Curr Opin Lipidol; 2006 Oct; 17(5):519-26. PubMed ID: 16960500
[TBL] [Abstract][Full Text] [Related]
2. Low dose oral cannabinoid therapy reduces progression of atherosclerosis in mice.
Steffens S; Veillard NR; Arnaud C; Pelli G; Burger F; Staub C; Karsak M; Zimmer A; Frossard JL; Mach F
Nature; 2005 Apr; 434(7034):782-6. PubMed ID: 15815632
[TBL] [Abstract][Full Text] [Related]
3. Cannabinoid signaling in glial cells.
Stella N
Glia; 2004 Dec; 48(4):267-77. PubMed ID: 15390110
[TBL] [Abstract][Full Text] [Related]
4. Role of lipids and lipid signaling in the development of cannabinoid tolerance.
Martin BR
Life Sci; 2005 Aug; 77(14):1543-58. PubMed ID: 15949820
[TBL] [Abstract][Full Text] [Related]
5. Cannabinoid receptor ligands as potential anticancer agents--high hopes for new therapies?
Oesch S; Gertsch J
J Pharm Pharmacol; 2009 Jul; 61(7):839-53. PubMed ID: 19589225
[TBL] [Abstract][Full Text] [Related]
6. The future of cannabinoids as analgesic agents: a pharmacologic, pharmacokinetic, and pharmacodynamic overview.
McCarberg BH; Barkin RL
Am J Ther; 2007; 14(5):475-83. PubMed ID: 17890938
[TBL] [Abstract][Full Text] [Related]
7. Cannabinoids and atherosclerosis.
Fisar Z
Prague Med Rep; 2009; 110(1):5-12. PubMed ID: 19591373
[TBL] [Abstract][Full Text] [Related]
8. The cannabinoid system and immune modulation.
Klein TW; Newton C; Larsen K; Lu L; Perkins I; Nong L; Friedman H
J Leukoc Biol; 2003 Oct; 74(4):486-96. PubMed ID: 12960289
[TBL] [Abstract][Full Text] [Related]
9. The endogenous cardiac cannabinoid system: a new protective mechanism against myocardial ischemia.
Lamontagne D; Lépicier P; Lagneux C; Bouchard JF
Arch Mal Coeur Vaiss; 2006 Mar; 99(3):242-6. PubMed ID: 16618028
[TBL] [Abstract][Full Text] [Related]
10. Cannabinoids in the treatment of pain and spasticity in multiple sclerosis.
Smith PF
Curr Opin Investig Drugs; 2002 Jun; 3(6):859-64. PubMed ID: 12137404
[TBL] [Abstract][Full Text] [Related]
11. [Cardiovascular effects of cannabinoids].
Járai Z; Kúnos G
Orv Hetil; 2002 Jun; 143(26):1563-8. PubMed ID: 12140859
[TBL] [Abstract][Full Text] [Related]
12. Cannabinoid analgesia as a potential new therapeutic option in the treatment of chronic pain.
Burns TL; Ineck JR
Ann Pharmacother; 2006 Feb; 40(2):251-60. PubMed ID: 16449552
[TBL] [Abstract][Full Text] [Related]
13. Cannabinoid receptors in brain: pharmacogenetics, neuropharmacology, neurotoxicology, and potential therapeutic applications.
Onaivi ES
Int Rev Neurobiol; 2009; 88():335-69. PubMed ID: 19897083
[TBL] [Abstract][Full Text] [Related]
14. Cannabinoid receptors 1 and 2 (CB1 and CB2), their distribution, ligands and functional involvement in nervous system structures--a short review.
Svízenská I; Dubový P; Sulcová A
Pharmacol Biochem Behav; 2008 Oct; 90(4):501-11. PubMed ID: 18584858
[TBL] [Abstract][Full Text] [Related]
15. On the pharmacological properties of Delta9-tetrahydrocannabinol (THC).
Costa B
Chem Biodivers; 2007 Aug; 4(8):1664-77. PubMed ID: 17712813
[TBL] [Abstract][Full Text] [Related]
16. Towards a therapeutic use of selective CB2 cannabinoid receptor ligands for atherosclerosis.
Steffens S; Mach F
Future Cardiol; 2006 Jan; 2(1):49-53. PubMed ID: 19804131
[TBL] [Abstract][Full Text] [Related]
17. Development of a novel class of monocyclic and bicyclic alkyl amides that exhibit CB1 and CB2 cannabinoid receptor affinity and receptor activation.
Berglund BA; Fleming PR; Rice KC; Shim JY; Welsh WJ; Howlett AC
Drug Des Discov; 2000; 16(4):281-94. PubMed ID: 10807034
[TBL] [Abstract][Full Text] [Related]
18. The endocannabinoid system and its therapeutic exploitation.
Di Marzo V; Bifulco M; De Petrocellis L
Nat Rev Drug Discov; 2004 Sep; 3(9):771-84. PubMed ID: 15340387
[TBL] [Abstract][Full Text] [Related]
19. Cannabinoids and the immune system: an overview.
Tanasescu R; Constantinescu CS
Immunobiology; 2010 Aug; 215(8):588-97. PubMed ID: 20153077
[TBL] [Abstract][Full Text] [Related]
20. The role of the endocannabinoid system in atherosclerosis.
Mach F; Steffens S
J Neuroendocrinol; 2008 May; 20 Suppl 1():53-7. PubMed ID: 18426500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
